By Scientia Professor Matthew Colm Kiernan

Journal articles

Ribeiro FL; Zhu X; Ye X; Tu S; Ngo ST; Henderson RD; Steyn FJ; Kiernan MC; Barth M; Bollmann S; Shaw TB, 2025, 'An Annotated Multi-Site and Multi-Contrast Magnetic Resonance Imaging Dataset for the study of the Human Tongue Musculature', Scientific Data, 12, http://dx.doi.org/10.1038/s41597-025-05092-8

Krishnan D; Talbot DL; Ashhurst JF; Park SB; Vucic S; Timmins HC; Kiernan MC, 2025, 'Longitudinal assessment of cortical motor function in amyotrophic lateral sclerosis', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-01570-6

Grima N; Smith AN; Shepherd CE; Henden L; Zaw T; Carroll L; Rowe DB; Kiernan MC; Blair IP; Williams KL, 2025, 'Multi-region brain transcriptomic analysis of amyotrophic lateral sclerosis reveals widespread RNA alterations and substantial cerebellum involvement', Molecular Neurodegeneration, 20, http://dx.doi.org/10.1186/s13024-025-00820-5

Graco M; Berlowitz DJ; Sawyer A; Holland AE; Carey KA; Ahamed Y; Ridgers A; Lannin NA; Wu P; Wheatley J; Vucic OS; Viera Souza T; Singh B; Thomas G; Talman P; Szollosi I; Sheean B; Rowe D; Rautela L; Piper A; Michael C; Menadue C; McLean A; Kosky C; Kiernan M; Howard ME; Hannan L; Dalziel K; Curtin D; Chao C; Braat S; Aiyappan V; Aickelin U, 2025, 'Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): protocol for a process evaluation of a clinical trial', Trials, 26, http://dx.doi.org/10.1186/s13063-025-08784-z

Berlowitz DJ; Rowe D; Howard ME; Piper A; Graco M; Braat S; Singh B; Souza TV; Lannin N; McLean A; Sawyer A; Carey KA; Ahamed Y; Wu P; Wheatley J; Vucic OS; Thomas G; Talman P; Szollosi I; Sheean B; Rautela L; Michael C; Menadue C; Kosky C; Kiernan M; Holland A; Hannan L; Dalziel K; Curtin D; Chao C; Aiyappan V; Aickelin U, 2025, 'Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): study protocol for a randomised controlled trial', Trials, 26, http://dx.doi.org/10.1186/s13063-024-08464-4

Calma AD; Pavey N; Silva CS; van den Bos MAJ; Yiannikas C; Farrar MA; Kiernan MC; Menon P; Vucic S, 2025, 'Diagnostic utility of threshold tracking TMS paradigms in early amyotrophic lateral sclerosis', Clinical Neurophysiology, 174, pp. 105 - 113, http://dx.doi.org/10.1016/j.clinph.2025.03.044

Swart G; Garg N; Skolka M; Yiannikas C; Vucic OS; Pollard J; Carroll A; Spies J; Kiernan M; Klein C; Park S, 2025, 'Application of a Clinical-electrophysiologic Model for Distinguishing Chronic Inflammatory Demyelinating Neuropathy (CIDP) in an Australian Cohort (P10-11.033)', Neurology, 104, http://dx.doi.org/10.1212/wnl.0000000000212523

Eisen A; Vucic S; Kiernan MC, 2025, 'Amyotrophic lateral sclerosis represents corticomotoneuronal system failure', Muscle and Nerve, 71, pp. 499 - 511, http://dx.doi.org/10.1002/mus.28290

van den Bos MAJ; Menon P; Pavey N; Higashihara M; Kiernan MC; Vucic S, 2025, 'Direct interrogation of cortical interneuron circuits in amyotrophic lateral sclerosis', Brain, 148, pp. 1169 - 1179, http://dx.doi.org/10.1093/brain/awae317

Kiernan MC; Timmins HC, 2025, 'Utility of the Gold Coast criteria for amyotrophic lateral sclerosis: Experience with fast progressors', Journal of the Neurological Sciences, 470, http://dx.doi.org/10.1016/j.jns.2025.123417

Almgren H; Mahoney CJ; Huynh W; D’Souza A; Berte S; Lv J; Wang C; Kiernan MC; Calamante F; Tu S, 2025, 'Quantifying neurodegeneration within subdivisions of core motor pathways in amyotrophic lateral sclerosis using diffusion MRI', Journal of Neurology, 272, http://dx.doi.org/10.1007/s00415-025-12920-9

Kiernan MC, 2025, 'Recent developments in consensus diagnostic criteria for amyotrophic lateral sclerosis', Eneurologicalsci, 38, http://dx.doi.org/10.1016/j.ensci.2025.100559

Hannaford A; Pavey N; Menon P; van den Bos MAJ; Kiernan MC; Simon N; Vucic S, 2025, 'Muscle ultrasound aids diagnosis in amyotrophic lateral sclerosis', Clinical Neurophysiology, 170, pp. 234 - 243, http://dx.doi.org/10.1016/j.clinph.2024.11.008

Vucic S; Pavey N; Menon P; Babayev M; Maslyukova A; Muraviev A; Kiernan MC, 2025, 'Neurophysiological assessment of cortical motor function: A direct comparison of methodologies', Clinical Neurophysiology, 170, pp. 14 - 21, http://dx.doi.org/10.1016/j.clinph.2024.12.001

Badrising UA; Henderson R; Reddel S; Corbett A; Liang C; Reardon K; Ghaoui R; Bulsara M; Brady S; Brusch A; Chan D; Coudert JD; Fairchild T; Jain G; Kiernan MC; Leonard D; Lloyd T; Schmidt J; McDermot MP; Sanders L; Lowe C; van der Kooi AJ; Weihl C; Mohassel P; Simpson M; Carrol A; Cooper I; Beer K; Hiscock K; Walters S; Panicker A; Doverty A; Heim AJ; van Heur-Neuman M; Benveniste O; Dimachki MM; Needham M, 2025, 'Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale', Clinical and Experimental Rheumatology, 43, pp. 316 - 325, http://dx.doi.org/10.55563/clinexprheumatol/zvffa0

Eisen A; Kiernan MC, 2025, 'The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations', Brain Sciences, 15, http://dx.doi.org/10.3390/brainsci15020195

Feldman EL; Sattler R; Kiernan MC; Goutman SA; Chiò A; Al-Chalabi A, 2025, 'Transforming amyotrophic lateral sclerosis into a liveable disease', Lancet Neurology, 24, pp. 100 - 101, http://dx.doi.org/10.1016/S1474-4422(24)00523-4

Koren TJ; Kiernan MC, 2025, 'Post-infectious acute cerebellar ataxia in a young adult', BMJ Case Reports, 18, http://dx.doi.org/10.1136/bcr-2024-262043

Kiernan MC; Davis SM, 2025, 'Stroke is not optional for neurologists', Practical Neurology, 25, pp. 2 - 3, http://dx.doi.org/10.1136/pn-2024-004230

Ziser L; van Eijk RPA; Kiernan MC; McRae A; Henderson RD; Schultz D; Needham M; Mathers S; McCombe P; Talman P; Vucic S, 2025, 'Amyotrophic lateral sclerosis established as a multistep process across phenotypes', European Journal of Neurology, 32, http://dx.doi.org/10.1111/ene.16532

O'Keefe E; Kiernan M; Huynh W, 2025, 'Cerebrotendinous xanthomatosis: A complex interplay between a clinically and genetically heterogeneous condition', European Journal of Neurology, 32, http://dx.doi.org/10.1111/ene.70006

Mazumder S; Carroll AS; Timmins HC; Kiernan MC; Mahoney CJ, 2025, 'Impact of the COVID-19 pandemic on the mental and physical wellbeing of patients with motor neuron disease and other neuromuscular disease', Frontiers in Neurology, 16, http://dx.doi.org/10.3389/fneur.2025.1514983

Pavey N; Menon P; Peterchev A; Kiernan M; Vucic S, 2025, 'Abnormalities of cortical stimulation strength-duration time constant in amyotrophic lateral sclerosis', Brain Stimulation, 18, pp. 311 - 312, http://dx.doi.org/10.1016/j.brs.2024.12.293

Santos Silva C; Pavey N; Calma AD; Kiernan MC; Menon P; van den Bos M; Vucic S, 2025, 'Utility of Cortical Inhibitory and Facilitatory Neuronal Circuits in Amyotrophic Lateral Sclerosis Diagnosis.', Eur J Neurol, 32, pp. e70203, http://dx.doi.org/10.1111/ene.70203

Tu S; Li T; Carroll AS; Mahoney CJ; Huynh W; Park SB; Henderson R; Vucic S; Kiernan MC; Lin CSY, 2024, 'Central neurodegeneration in Kennedy’s disease accompanies peripheral motor dysfunction', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-69393-5

J M Dick T; Tucker K; Hug F; Besomi M; van Dieën JH; Enoka RM; Besier T; Carson RG; Clancy EA; Disselhorst-Klug C; Falla D; Farina D; Gandevia S; Holobar A; Kiernan MC; Lowery M; McGill K; Merletti R; Perreault E; Rothwell JC; Søgaard K; Wrigley T; Hodges PW, 2024, 'Consensus for experimental design in electromyography (CEDE) project: Application of EMG to estimate muscle force', Journal of Electromyography and Kinesiology, 79, pp. 102910, http://dx.doi.org/10.1016/j.jelekin.2024.102910

Timmins HC; Thompson AE; Kiernan MC, 2024, 'Diagnostic criteria for amyotrophic lateral sclerosis', Current Opinion in Neurology, 37, pp. 570 - 576, http://dx.doi.org/10.1097/WCO.0000000000001302

Kiernan MC; Kaji R, 2024, 'Emerging concepts and therapies for amyotrophic lateral sclerosis', Current Opinion in Neurology, 37, pp. 558 - 559, http://dx.doi.org/10.1097/WCO.0000000000001308

Tu S; Vucic S; Kiernan MC, 2024, 'Pathological insights derived from neuroimaging in amyotrophic lateral sclerosis: Emerging clinical applications', Current Opinion in Neurology, 37, pp. 577 - 584, http://dx.doi.org/10.1097/WCO.0000000000001295

Devenney EM; Anh N Nguyen Q; Tse NY; Kiernan MC; Tan RH, 2024, 'A scoping review of the unique landscape and challenges associated with dementia in the Western Pacific region', Lancet Regional Health Western Pacific, 50, http://dx.doi.org/10.1016/j.lanwpc.2024.101192

Timmins HC; Mok VCT; Kim SH; Shahrizaila N; Sung JY; Sobue G; Agustini S; Ward S; Anstey KJ; Talbot DL; Mazumder S; Tu S; Tan RH; Shin-Yi Lin C; O'Callaghan C; Michaelian JC; Jeon YH; Foxe D; Naismith SL; Piguet O; Ahmed R; Devenney E; Park SB; Kiernan MC, 2024, 'Regional health priorities for dementia: a roadmap for the Western Pacific', Lancet Regional Health Western Pacific, 50, pp. 101179, http://dx.doi.org/10.1016/j.lanwpc.2024.101179

Clarke AJ; Brodtmann A; Irish M; Mowszowski L; Radford K; Naismith SL; Mok VCT; Kiernan MC; Halliday GM; Ahmed RM, 2024, 'Risk factors for the neurodegenerative dementias in the Western Pacific region', Lancet Regional Health Western Pacific, 50, http://dx.doi.org/10.1016/j.lanwpc.2024.101051

Reynolds M; Tan I; Nguyen K; Merheb V; Lee FXZ; Trewin BP; Lerch M; Shah S; Wolfe N; Buzzard K; Lechner-Scott J; Fabis-Pedrini M; Fok A; John N; Kneebone C; Yiannikas C; Brown DA; Kermode AG; Reddel S; Dale RC; Brilot F; Ramanathan S; Adam R; Andersen J; Andrews I; Antony J; Aouad P; Badve M; Barnett MH; Barton J; Beadnall H; Blum S; Boggild M; Broadley S; Burrow J; Butzkueven H; Bye A; Cairns A; Calvert S; Chan F; Chelakkadan S; Chu M; Clark DR; Cotter I; Dela Cruz F; Field D; Fraser CL; Fung VSC; Garber J; Geara S; Gill D; Gupta S; Hardy TA; Hawke S; Henderson APD; Jeyakumar N; Jones DL; Jones HF; Kalincik T; Kiernan M; Kilpatrick T; Kornberg AJ; Lawlor M; Leventer RJ; Li V; Ling S; Liyanage G; Lopez JA; Ma KKM; Malone S; Marriot MP; McCombe P; McDougall A; Menezes MP; Miteff C; Monif M; Musuwadi Subramanian G; Nguyen AL; O'Grady G; Ouvrier R; Paine M; Parratt J; Pillai S; Prosser J; Qiu J, 2024, 'The clinical relevance of MOG antibody testing in cerebrospinal fluid', Annals of Clinical and Translational Neurology, 11, pp. 2514 - 2519, http://dx.doi.org/10.1002/acn3.52163

Li T; Timmins HC; Mahfouz FM; Trinh T; Mizrahi D; Horvath LG; Harrison M; Grimison P; Friedlander M; Marx G; Boyle F; Wyld D; Henderson R; King T; Baron-Hay S; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy', JAMA Network Open, 7, pp. e2424139, http://dx.doi.org/10.1001/jamanetworkopen.2024.24139

Rahiman K J, 2024, 'Chemotherapy-Induced Neurotoxicity', International Journal of Science and Research (IJSR), 13, pp. 1250 - 1254, http://dx.doi.org/10.21275/sr24820170848

Pavey NA; Menon P; Peterchev AV; Kiernan MC; Vucic S, 2024, 'Abnormalities of cortical stimulation strength-duration time constant in amyotrophic lateral sclerosis', Clinical Neurophysiology, 164, pp. 161 - 167, http://dx.doi.org/10.1016/j.clinph.2024.05.014

Pavey N; Hannaford A; Van Den Bos M; Kiernan MC; Menon P; Vucic S, 2024, 'Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis', Brain, 147, pp. 2344 - 2356, http://dx.doi.org/10.1093/brain/awae049

Gray E; Menadue C; Piper A; Wong K; Yee B; Kiernan M, 2024, 'Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry', Erj Open Research, 10, http://dx.doi.org/10.1183/23120541.00927-2023

Dharmadasa T; Pavey N; Tu S; Menon P; Huynh W; Mahoney CJ; Timmins HC; Higashihara M; van den Bos M; Shibuya K; Kuwabara S; Grosskreutz J; Kiernan MC; Vucic S, 2024, 'Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter', Clinical Neurophysiology, 163, pp. 68 - 89, http://dx.doi.org/10.1016/j.clinph.2024.04.010

Higashihara M; Pavey N; Menon P; van den Bos M; Shibuya K; Kuwabara S; Kiernan MC; Koinuma M; Vucic S, 2024, 'Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study', European Journal of Neurology, 31, http://dx.doi.org/10.1111/ene.16281

Besomi M; Devecchi V; Falla D; McGill K; Kiernan MC; Merletti R; van Dieën JH; Tucker K; Clancy EA; Søgaard K; Hug F; Carson RG; Perreault E; Gandevia S; Besier T; Rothwell JC; Enoka RM; Holobar A; Disselhorst-Klug C; Wrigley T; Lowery M; Farina D; Hodges PW, 2024, 'Consensus for experimental design in electromyography (CEDE) project: Checklist for reporting and critically appraising studies using EMG (CEDE-Check)', Journal of Electromyography and Kinesiology, 76, http://dx.doi.org/10.1016/j.jelekin.2024.102874

Li T; Timmins HC; Mahfouz FM; Mizrahi D; Horvath L; Harrison ML; Grimison PS; Friedlander M; Marx GM; Boyle FM; Wyld D; Henderson R; King T; Baron-Hay SE; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Identifying optimized assessment of nerve damage during chemotherapy.', Journal of Clinical Oncology, 42, pp. 12016 - 12016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.12016

Li T; Trinh T; Bosco A; Kiernan MC; Goldstein D; Park SB, 2024, 'Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-024-08484-5

Eisen A; Pioro EP; Goutman SA; Kiernan MC, 2024, 'Nanoplastics and Neurodegeneration in ALS', Brain Sciences, 14, http://dx.doi.org/10.3390/brainsci14050471

Silsby M; Yiannikas C; Fois AF; Kennerson ML; Kiernan MC; Fung VSC; Vucic S, 2024, 'Upper and lower limb tremor in Charcot–Marie–Tooth neuropathy type 1A and the implications for standing balance', Journal of Neurology, 271, pp. 1776 - 1786, http://dx.doi.org/10.1007/s00415-023-12124-z

Carroll AS; Park SB; Lin CSY; Taylor MS; Kwok F; Simon NG; Reilly MM; Kiernan MC; Vucic S, 2024, 'Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis', Clinical Neurophysiology, 159, pp. 81 - 95, http://dx.doi.org/10.1016/j.clinph.2024.01.006

Eisen A; Nedergaard M; Gray E; Kiernan MC, 2024, 'The glymphatic system and Amyotrophic lateral sclerosis', Progress in Neurobiology, 234, http://dx.doi.org/10.1016/j.pneurobio.2024.102571

Silsby M; Yiannikas C; Fois AF; Kiernan MC; Fung VSC; Vucic S, 2024, 'Upper and lower limb tremor in inflammatory neuropathies', Clinical Neurophysiology, 158, pp. 69 - 78, http://dx.doi.org/10.1016/j.clinph.2023.12.005

Devenney EM; Tse NY; O’Callaghan C; Kumfor F; Ahmed RM; Caga J; Hazelton JL; Carrick J; Halliday GM; Piguet O; Kiernan MC; Hodges JR, 2024, 'An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia', Brain Communications, 6, http://dx.doi.org/10.1093/braincomms/fcae123

Carroll AS; Razvi Y; O’Donnell L; Veleva E; Heslegrave A; Zetterberg H; Vucic S; Kiernan MC; Rossor AM; Gillmore JD; Reilly MM, 2024, 'Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice', Amyloid, 31, pp. 95 - 104, http://dx.doi.org/10.1080/13506129.2024.2313218

Back to profile page